Cellectis (NASDAQ: CLLS) reported Q3 EPS of ($0.36), versus ($0.36) reported last year. Revenue for the quarter came in at $9.98 million, versus $11.31 million reported last year.

For earnings history and earnings-related data on Cellectis (CLLS) click here.